The legitimacy of prestigious medical and scientific journals is under siege as the Trump administration threatens to take federal research elsewhere and scrutiny falls on their alleged coziness with regulators, interest groups and drugmakers, with perhaps the most serious consequences in the integrity of COVID-19 origin research.